Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

maintenance therapy

  • You have access
    A Randomized Phase II Study of Maintenance Bevacizumab, Pemetrexed or Bevacizumab Plus Pemetrexed for Advanced Non-squamous Non-small Cell Lung Cancer
    HIRONORI YOSHIDA, YOUNG HAK KIM, YUICHI SAKAMORI, HIROKI NAGAI, HIROAKI OZASA, TOSHIHIKO KANEDA, HIROSHIGE YOSHIOKA, HIROAKI NAKAGAWA, KEISUKE TOMII, ASUKA OKADA, KENICHI YOSHIMURA, MASATAKA HIRABAYASHI and TOYOHIRO HIRAI
    Anticancer Research May 2020, 40 (5) 2981-2987; DOI: https://doi.org/10.21873/anticanres.14278
  • You have access
    Incorporating Bortezomib in the Management of Plasmablastic Lymphoma
    ONYEDIKA UMEANAETO, JOSEPH GAMBOA, JESUS DIAZ, M. NAWAR HAKIM, JAVIER CORRAL, ALEXANDER PHILIPOVSKIY and SUMIT GAUR
    Anticancer Research September 2019, 39 (9) 5003-5007; DOI: https://doi.org/10.21873/anticanres.13690
  • You have access
    Impact of Maintenance Therapy for Patients with Non-small Cell Lung Cancer in a Real-world Setting
    KIYOTAKA YOH, YASUSHI GOTO, YOICHI NAITO, KAZUMA KISHI, KIYOSHI MORI, KATSUYUKI HOTTA, YUKIO HOSOMI, KAZUHIKO YAMADA, CHIHARU TANAI, YOSHIO TOMIZAWA, AKIRA INOUE, YOSHINORI HASEGAWA, MAKOTO NISHIO, YASUO OHASHI and HIDEO KUNITOH
    Anticancer Research March 2017, 37 (3) 1507-1513;
  • You have access
    Importance of Bevacizumab Maintenance Following Combination Chemotherapy in Human Non–small Cell Lung Cancer Xenograft Models
    NOBUYUKI ISHIKURA, MIEKO YANAGISAWA, MARIKO NOGUCHI-SASAKI, TOSHIKI IWAI, KEIGO YOROZU, MITSUE KURASAWA, MASAMICHI SUGIMOTO and KANAME YAMAMOTO
    Anticancer Research February 2017, 37 (2) 623-629;
  • You have access
    Bevacizumab Combined with Docetaxel or Paclitaxel as First-line Treatment of HER2-negative Metastatic Breast Cancer
    LEENA TIAINEN, MINNA TANNER, OUTI LAHDENPERÄ, PIA VIHINEN, ARJA JUKKOLA, PEETER KARIHTALA, NIINA PAUNU, TEPPO HUTTUNEN and PIRKKO-LIISA KELLOKUMPU-LEHTINEN
    Anticancer Research December 2016, 36 (12) 6431-6438;
  • You have access
    Sphingosine Kinase Inhibitors as Maintenance Therapy of Glioblastoma After Ceramide-Induced Response
    LAURA A. SORDILLO, PETER P. SORDILLO and LAWRENCE HELSON
    Anticancer Research May 2016, 36 (5) 2085-2095;
Anticancer Research

© 2023 Anticancer Research

Powered by HighWire